Careium (CARE) ABGSC Investor Days summary
Event summary combining transcript, slides, and related documents.
ABGSC Investor Days summary
12 Jan, 2026Market trends and demographic shifts
Europe faces an irreversible demographic shift, with one-third of its population projected to be over 65 by 2060, driving demand for technology-enabled care solutions.
Rising care costs and changing tax bases are pushing governments and markets to adopt innovative, technology-driven care models.
Penetration rates for care technology vary widely across Europe, with the UK leading at 15-16% and Germany and France lagging at around 5%.
The sector is expected to grow at a 7-8% CAGR in the coming years, fueled by digital infrastructure upgrades and aging populations.
Gradual demographic changes are creating a slow but inevitable inflection point for investment in care technology.
Business model and operations
Focuses on technology-enabled care for individuals at home, offering hardware, software, and direct services, with a strong emphasis on recurring revenue.
Currently serves 515,000 people across Europe, with 340,000 receiving direct services.
Revenue is 70% recurring, mainly from long-term contracts with municipalities, insurance companies, and B2B/B2C channels.
No immediate plans for broad geographic expansion, except for increased commercial activity in Spain.
The company was spun out of Doro in 2021 and has stabilized after initial integration and performance challenges.
Strategic priorities and growth plans
Prioritizing organic growth in large European markets like France, Spain, and Germany, with strong recent performance in these regions.
Investing in product innovation, such as the i-Care Center alarm platform, tailored for the senior care sector.
Exploring entry into the assisted living segment and expanding B2C offerings for higher margins.
Actively seeking acquisition opportunities, focusing on integration and cost synergies, with a cautious but increasingly aggressive approach.
Spain is a key target market, with a tender-centric approach and expectations for revenue generation in 2025.
Latest events from Careium
- Sales fell 7.2% in Q3, but solid margins and innovation support 2024 growth targets.CARE
Q3 202411 Jun 2026 - Strong sales, profit growth, and margin expansion set the stage for further gains in 2025.CARE
Q4 202411 Jun 2026 - Gross margin improved to 44.5% despite lower sales and profit, with growth outside Sweden.CARE
Q1 202511 Jun 2026 - Sales and profit fell, but gross margin and cash flow improved; outlook remains positive.CARE
Q2 202511 Jun 2026 - Q2 net sales rose 7.3% and EBIT increased 48.9%, led by strong growth in Germany and France.CARE
Q2 202421 May 2026 - Net sales and profit rose, but margins declined due to investments and onboarding costs.CARE
Q1 20265 May 2026 - Q4 2025 delivered modest sales growth, lower EBIT, and stronger cash flow amid margin pressure.CARE
Q4 202516 Feb 2026 - Q3 2025 delivered 6% sales growth, higher margins, and strong product sales despite one-off costs.CARE
Q3 202524 Oct 2025